Market News
Stay updated with the latest market trends, earnings, and economic indicators.
US drug tariff risk limited for Indian pharma; Sun Pharma exposure in focus: Vishal Manchanda
According to Vishal Manchanda, Pharma Analyst, Systematix Group, potential US action on drug pricing is seen as focused on patented medicines, limiting direct impact on Indian generic manufacturers. Companies with higher exposure to specialty drugs may need to consider pricing agreements to avoid penalties. The expected earnings impact for affected firms remains contained. Sector dynamics continue to favour businesses with lower dependence on US generics, while policy developments and ongoing investigations remain key factors to monitor.
USFDA action on Eugia unit II puts Aurobindo Pharma shares in focus
The inspection at Unit II was conducted between November 3 and November 14, during which the regulator issued nine observations.
Stocks to Watch today: ACME Solar, Gravita India, Kalpataru, Raymond Realty
Stocks to Watch today, March 13: Aurobindo Pharma, Godrej Properties, KPI Green Energy, JK Lakshmi Cement, Max Financial Services, and Nectar Lifesciences are among the top stocks to remain in focus
Stocks to watch: Tata Steel, Adani Ports, Biocon, IOB among 10 shares in focus on Friday - March 13
Stock market today: The Indian stock market remained under bearish pressure as the benchmark Sensex plunged another 800 points, or about 1%, on Thursday, March 12.
Nuvama Share Price In Focus As Healthcare Sector Expansion Gains Attention | Stock Market Today - Samco
Nuvama Share Price In Focus As Healthcare Sector Expansion Gains Attention | Stock Market TodaySamco
Hyatt elevates Sunjae Sharma to Asia Pacific leadership role; Vikas Chawla to head India operations
David Udell, group president for Hyatt's Asia Pacific operations, said Sunjae Sharma would take on broader regional responsibilities as the hotel chain sharpens its focus on growth across the region
35.66% YTD return: Healthcare stock in focus post this report amid volatility in stock market - India TV News
35.66% YTD return: Healthcare stock in focus post this report amid volatility in stock marketIndia TV News
Stocks in news: Kwality Walls, AU Small Finance Bank, YES Bank, PB Fintech, Tata Power
Indian markets faced pressure on Friday, losing some recent gains due to cautious global sentiment and profit-taking. Several companies like PB Fintech, Kwality Walls, Cipla, AU Small Finance Bank, YES Bank, and Tata Power are in focus. Block deals occurred in PB Fintech. Kwality Walls reported Q3FY26 revenue. Cipla is recalling medication in the US.
Avoid chasing metal rally; focus on domestic sectors: Jyotivardhan Jaipuria
Jyotivardhan Jaipuria, Founder & MD of Valentis Advisors, says market corrections during geopolitical conflicts historically present buying opportunities, though investors should stagger investments due to oil and gas risks. He remains positive on banks, select capital goods and pharmaceuticals, while continuing to hold metals but avoiding fresh buying at current levels. Export-oriented sectors like chemicals may face near-term pressure from higher logistics and raw material costs.
Novo Holdings scales up India bets with bigger cheques, focus on mature healthcare assets
The life sciences investor is increasing ticket sizes and doubling down on speciality care and healthcare services as India emerges as a key deployment market in Asia.
Samsung plans to take AI to entry-price smartphones, expand portfolio of Galaxy A series in India
Samsung is extending advanced Artificial Intelligence capabilities to its budget-friendly smartphones, aiming to broaden the AI phone segment. The brand is ramping up investments in retail infrastructure, with a strong focus on smaller cities and emerging markets. By keeping prices accessible, Samsung plans to make AI-driven devices mainstream and foresees AI phones overtaking traditional smartphones as the new standard.
Indian drugmaker Sai Life Sciences to boost headcount by about 20% amid global demand upswing
Sai Life Sciences will boost its workforce by over 700 employees next financial year. This expansion supports growing global demand for its services. The company is increasing capacity to meet this demand. New hires will focus on scientific, technical, and management roles. This move reflects a broader trend of global pharma companies expanding in India.